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Rubinstein-Taybi syndrome (RSTS) is an inheritable disease associated with mutations in the gene encoding the CREB (cAMP response
element-binding protein)-binding protein (CBP) and characterized by growth impairment, learning disabilities, and distinctive facial
and skeletal features. Studies in mouse models for RSTS first suggested a direct role for CBP and histone acetylation in cognition and
memory. Here, we took advantage of the genetic tools for generating mice in which the CBP gene is specifically deleted in postmitotic
principalneuronsof the forebrain to investigate the consequencesof the lossofCBP in theadult brain. In contrast to the conventionalCBP
knock-out mice, which exhibit very early embryonic lethality, postnatal forebrain-restricted CBPmutants were viable and displayed no
overt abnormalities.We identified the dimer of histonesH2A andH2B as the preferred substrate of the histone acetyltransferase domain
of CBP. Surprisingly, the loss of CBP and subsequent histone hypoacetylation had a verymodest impact in the expression of a number of
immediate early genes and did not affect neuronal viability. In addition, the behavioral characterization of these mice dissociated
embryonic and postnatal deficits caused by impaired CBP function, narrowed down the anatomical substrate of specific behavioral
defects, and confirmed the special sensitivity of object recognitionmemory to CBP deficiency. Overall, our study provides novel insights
intoRSTS etiology and clarifies some of the standing questions concerning the role of CBP andhistone acetylation in activity-driven gene
expression, memory formation, and neurodegeneration.
Introduction
TheRubinstein-Taybi syndrome (RSTS) is a rare inheritable disease
associated with mutations in either one of two related genes encod-
ing transcriptional coactivators with lysine acetyltransferase activity
(KAT) [previously referred to as histone acetyltransferase activity, or
HAT (Allis et al., 2007)]: the cAMP-response element binding pro-
tein (CREB)-bindingprotein (CBP),whosegene (crebbp) ismutated
in60%of the patients (Petrij et al., 1995) and p300, paralogous to
CBP and responsible for3% of the cases (Roelfsema et al., 2005).
Children with RSTS display distinctive anatomical features, such as
hypertelorism, prominent nose, and broad thumbs and first toes
(Wiley et al., 2003), experiencedifficulties inplanning and executing
motor acts, andhave a short attention spanand low intelligence level
(Gotts and Liemohn, 1977; Hennekam et al., 1992).
Recent studies in RSTS mouse models have provided impor-
tant new insights into the etiology of this condition and demon-
strated a good correlation between reduced KAT activity and
deficits in synaptic plasticity andmemory (Bourtchouladze et al.,
2003; Alarco´n et al., 2004; Korzus et al., 2004; Wood et al., 2005,
2006; Viosca et al., 2010). Moreover, because intellectual abilities
rely on the ability to store and retrieve information and memory
storage is known to depend on de novo gene expression, it has
been proposed that the reduced histone acetylation in CBP-
deficientmicemay cause themisregulation of the transcription of
loci important in neural plasticity and thus contribute to the ob-
served cognitive impairments (Barco, 2007). Although RSTS is
not a neurodegenerative disease and no cell loss has been re-
ported in the different mouse models for this disorder, several
lines of evidence indicate that CBP and histone acetylation may
also play a role in the pathogenesis of diverse neurodegenerative
diseases (Saha and Pahan, 2006). Another interesting notion
emerging from studies on RSTS mouse models, in particular of
the reversal of phenotypical traits after pharmacological treat-
ment with inhibitors of histone deacetylases (HDACi), is that the
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cognitive and neurological deficits associated to RSTS may have
twodistinct components: one originated during the development
of the CNS, and a second one resulting from the continued re-
quirement of the enzymatic activity of CBP throughout life (Alar-
co´n et al., 2004; Korzus et al., 2004).
Previous loss-of-function approaches to investigate the role of
CBP in neuronal gene expression and survival were constrained
by the early embryonic lethality of CBP knock-out mice and the
partial or uncertain level of inhibition of CBP function in het-
erozygous and transgenic lines (Barco, 2007). Here, we address
some of the important questions raised in previous studies, such
as the substrate specificity of CBP and its role in neuronal survival
and activity-driven gene expression through the characterization
of a conditional knock-out mouse strain in which CBP expres-
sion is specifically lost in postmitotic forebrain neurons. We also
investigate the behavioral deficits associated with CBP deficiency
once the impact of developmental defects has been eliminated or
at least primarily reduced.
Materials andMethods
Animals and treatments. The generation of both CBPf/f (Zhang et al.,
2004) and CaMKII–cre (CKIIcre) (Tsien et al., 1996) mice has been
described previously. Mice were maintained and bred under standard
conditions, consistent with Spanish and European regulations and ap-
proved by the Institutional AnimalCare andUseCommittee. The genetic
background of all mice was C57BL/6J. Analyses were conducted in 2- to
4-month-old animals, except for the cell death analyses, in which a sec-
ond group of 8-month-old animals was also examined. Sodium butyrate
(NaBu) (1.2 mg/kg in PBS) was administered by intraperitoneal injec-
tion. Vehicle-treated mice received an injection of PBS. Sampling was
performed 30 min later, before the decay of the transient increase of
acetylation (data not shown). Exposure to novelty consisted of placing an
individual animal in a white Plexiglas square box (50  50  30 cm)
containing plastic tubings and small objects/toys of different shapes, col-
ors, and sizes for 1 h. Control animals were maintained in their standard
cages. Animals were rapidly killed to minimize the possible induction of
immediate early genes (IEG) by stress.
Plasmids and transient transfection of HEK293 cells. Standard manipu-
lations of Escherichia coli, cell culture, proteins, and nucleic acids were
performed essentially as described (Ausubel et al., 1999). For transfection
experiments in HEK293 cells, CBP and p300 coding sequences were
cloned in pMM400 vector (Mayford et al., 1996) that contain a tet-
responsive element and a minimal cytomegalovirus promoter, which
allowed inducible expression of the protein of interest. These plasmids
were cotransfectedwith either pTet–Off or pEGFP–N3 (Invitrogen). The
tTA protein expressed from pTet–Off strongly activates transcription of
CBP and p300 genes in the absence of doxycycline. HEK293 cells were
grown in 90% DMEM supplemented and 10% fetal calf serum sup-
plemented with 2 mM glutamine and penicillin/streptomycin (100
U/ml to 100 g/ml) (Invitrogen). HEK293 cells were transfected with
Lipofectamine 2000 (Invitrogen) following the instructions of the
manufacturer.
Western blot and immunohistochemistry.Nissl staining, immunohisto-
chemistry, and Western blot analysis were performed as previously de-
scribed (López de Armentia et al., 2007; Sanchís-Segura et al., 2009).
Microdissected CA1 subregions were used as source of protein extracts.
For immunohistochemistry, mice were anesthetized, perfused with
4% paraformaldehyde, and postfixed overnight, and 50 m sections
were obtained using a vibratome. Antibodies used in the present study
were as follows: -CBPC1 and c-fos antibodies (Santa Cruz Biotechnol-
ogy), -H2B and -H3 (Millipore Corporation), -neuronal-specific
nuclear protein (NeuN) (Millipore Corporation), -GFAP, -MAP2,
-synaptophysin,-actin, and biotinylated andHRP-conjugated-mouse
secondaryantibodies (Sigma-Aldrich),HRP-conjugated-rabbit secondary
antibody (Cell Signaling Technology), and Alexa Fluor 488, 555, and 594
secondaryantibodies (Invitrogen).Thedifferent-acetyl-histoneantibodies
were locally produced (Sanchís-Segura et al., 2009) except for the acetylated
lysine-specific antibodies (MilliporeCorporation). Cell counting and length
measurements were performed using NIH ImageJ software in images ob-
tainedwith confocalmicroscopy in single stacks or in a conventional epiflu-
orescencemicroscope. For each animal, twobrain sliceswere examined, and
the resulting values were averaged. For the quantification of CBP, c-fos, and
acetylhistones immunostainings, the signal intensities for single individual
nuclei in a frame (0.375 0.375 mm, confocal microscopy) were obtained
and normalized by the median of intensities to scale the values between
frames.
PCR, reverse transcription, and quantitative PCR. To obtain genomic
DNA, the tissues were treated with 100 l of 25 mM NaOH and 0.2 mM
EDTA, pH12, for 20min at 95°C and then bufferedwith an equal volume
of 1 M Tris-HCl, pH 5. PCR were set up using GoTaq DNA polymerase
(Promega): a final volume reaction of 25 l contained 1:20 dilutions of
DNA, 5Green buffer (Promega), 1.5mMMgCl2, 0.2mMdNTPmix, 0.5
mM each primer, and 0.625 U of GoTaq DNA polymerase. PCR was
performed for 30 cycles (1 min at 95°C, 1 min at 54°C, 1 min at 72°C).
The sequences of the primers Z38 and Z40 were as described previously
(Zhang et al., 2004).
In reverse transcription (RT)-PCR experiments, total RNA from
whole hippocampus, microdissected CA1 subregion, cortex, striatum
and cerebellum was purified using TRI reagent (Sigma) according to the
instructions of the manufacturer. One microgram was reverse tran-
scribed using RevertAid First Strand cDNA Synthesis kit (Fermentas).
Then, conventional PCR were performed using Pfu DNA polymerase
(Fermentas): a final volume reaction of 25 l contained 50 ng of cDNA,
10 buffer with 20 mMMgSO4, 0.2 mM dNTPmix, 0.5 mM each primer,
and 0.625 U of Pfu DNA polymerase. PCR was performed for 35 cycles
(45 s at 95°C, 45 s at 55°C, 1 min at 72°C). The sequences (from 5 to 3)
of the primers were as follows: 5 CREB binding domain (CBD), CG-
GCTCCATGGGTGCAGGGCAACAGAATGCCA; E8 reverse (E8rev),
AAGGAGGCGCTGCTGTAGGTAT. Quantitative RT-PCRs (qRT-PCR)
were performed in an Applied Biosystems 7300 real-time PCR unit using
SYBR GreenER mix (Invitrogen) and primers specific for CBP, p300, Arc,
c-fos, Npas4, Egr1, Nr4a1, FosB, Dusp1, and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH). All primer sequences are available on request.
Each independent sample was assayed in duplicate and normalized using
GAPDH levels.
Behavior. For all behavioral tasks, adult mutant and control littermate
males were used. The SHIRPA primary screen, open field, elevated plus
maze, and fear conditioning tasks were performed as described previ-
ously (Viosca et al., 2009, 2010). To studymotor coordination and learn-
ing, mice were trained on a rotarod (Ugo Basile) at a constant speed (4
rpm) four times per day during 2 d. On the testing day, the rotarod was
set to increase its speed 1 rpm every 16 s starting at 4 rpm, and the interval
to fall off was measured. For the analysis of circadian locomotor activity,
eachmousewas individually housed in a PhenoTyper cage (45 45 55
cm, length width height; Noldus Information Technology) during
5 d and 4 nights with water and food available ad libitum. All cages
contained a top unit with a digital video camera and infrared lights,
sawdust on the floor, and an immobile shelter. Data were acquired with
EthoVision video-tracking software (Noldus Information Technology)
for 3 consecutive days after 36 h of habituation. To evaluate nociception
and sensitivity to thermal stimulus, mice were placed in the test chamber
of a hotplate (IITC Life Science) set at 54°C, and the latency until the
animal exhibited heat pain behavior was recorded. All mice were tested
three times with 1 h interval between each measurement. In the novel
object recognition memory task, mice were habituated to an open blue
cylinder for 2 consecutive days (10 min/d). During training (third day),
themice explored for 20min two identical objects, and for testing (fourth
day), the animals were presented for 10min to one of the training objects
and to a novel object. The familiar and the novel objects differed in shape,
color, and texture and were located in the same positions in which the
objects were located during the training session. The use of different objects
as novel or familiar, as well as the relative position of the novel object, was
balanced between genotypes. Time spent exploring the objects in both the
training and testing sessions was measured with video-tracking system
(SMART; Panlab SL). The discrimination index (DI) was determined
using the following formula: DI  100  (time exploring A  time
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exploring B)/(time exploring A time exploring B). Spatial learning in
the Morris water maze (MWM) was assessed in a circular tank (170 cm
diameter) filled with opaque white water as described previously (Viosca
et al., 2009). Mice were monitored throughout the training and testing
sessions with a video-tracking system (Panlab SL). A platform of 10 cm
diameter was submerged 1 cmbelow thewater surface in the center of the
target quadrant. The training protocol, both when the platform was vis-
ible (3 d:V1 toV3) andhidden (8 d:H1 toH8), consisted of four trials per
day with a 45min intertrial interval. If themice did not find the platform
after 120 s, they were gently guided to it. Mice were transferred to their
cages only after remaining on the platform for at least 10 s. Memory
retention trials of 60 s were performed at the beginning of day H5 (probe
trial 1) and 24 h after concluding the training on day H8 (probe trial 2).
Statistical analyses used ANOVAs, and means  SEM are presented in
the figures. The experimenter was blind to genotypes, and the result of
the PCR-based genotyping was provided as a factor for statistical analysis
of the behavioral data once the battery of tasks was concluded.
Results
CBP depletion in principal forebrain neurons
To explore the consequences of the neuronal elimination of CBP
in adult brain function bypassing the embryonic lethality caused
byCBPdepletion, we producedmice bearing both a floxed crebbp
allele (CBPf) in homozygosity (Zhang et al., 2004) and the trans-
gene CaMKII–cre, which drives the expression of cre recombi-
nase in postmitotic principal neurons of the forebrain (Tsien et
al., 1996). This genetic manipulation results in mice that express
a truncated CBP protein (CBPstop523) that lacks KAT activity
(amino acids 1300–1700) and is also unable to interact with a
number of transcription factors involved in neuronal function,
such as CREB, c-fos, jun, nuclear factor-B, and others, because
critical domains (KIX, CH3) involved in these interactions are
encoded by exons downstream of the deletion (Chan and La
Thangue, 2001).
Previous work has demonstrated that both CBPf/f mice
(Zhang et al., 2004) and CaMKII–cre transgenic mice (Tsien et
al., 1996) are indistinguishable from wild-type mice. CaMKII–
cre/CBPf/f mice, from now on referred as CKIIcre/CBPf/f, have a
normal lifespan and show no overt anatomical or behavioral ab-
normality (Table 1). These initial observations suggest that, al-
though CBP is essential during embryonic development, it is
largely dispensable for the survival of postmitotic neurons. As
expected, given that themutation is restricted to postmitotic neu-
rons, CKIIcre/CBPf/f mice do not present the facial dismorphia
and skeletal defects observed in heterozygousmutants (Tanaka et
al., 2000; Viosca et al., 2010). Body weight and size were also
similar between genotypes, and even CKIIcre/CBPf/f mice were
slightly larger, indicating that the growth impairment observed in
heterozygous mice does not have a neurological origin or de-
pends on neuronal populations not affected in CKIIcre/CBPf/f
mice.
We confirmed cre-mediated recombination of the crebbp lo-
cus in genomic DNA samples. In agreement with the expected
pattern of cre recombinase expression, exon-specific PCR reac-
tions (Fig. 1A) demonstrated the extensive elimination of exon 7
in genomic DNA from the hippocampus, cortex, and striatum of
CKIIcre/CBPf/fmice (Fig. 1B). In contrast, we did not observe any
recombination in cerebellum in which the calcium/calmodulin-
dependent kinase II (CaMKII) promoter is not active (Fig.
1B). The elimination of exon 7 caused the production of a shorter
CBP transcript in the tissues expressing the cre recombinase (Fig.
1C). qRT-PCR analyses revealed that the amount of full-length
CBP transcripts was reduced in the same brain regions showing
recombination in the crebbp locus (Fig. 1D, Ex7-8 bars). The
reduction of full-length CBP transcripts was especially severe in
the cortex and in the hippocampus (71 and 35%, respec-
tively). As expected, this reduction did not reach 100%, because
the geneticmanipulation eliminatesCBP expression only in prin-
cipal neurons, whereas glial cells, interneurons, and other neural
typesmaintain normal expression of the crebbp gene. In addition,
not all the neurons in a given region expressed the cre recombi-
nase (see below). Interestingly, exon 7-lacking transcripts seemed
to be unstable, because we observed a significant reduction of
CBP transcripts also when the qRT-PCR was targeted to se-
quences downstream of the deletion (Fig. 1D, 3 bars).
Immunohistochemistry experiments using aCBP-specific an-
tibody confirmed the neuron-specific reduction of CBP in differ-
ent forebrain regions (Fig. 1E). In the hippocampus, the staining
revealed a scattered pattern for the loss of CBP in the pyramidal
cell layer of the CA1 subfield (Fig. 1F). The elimination of CBP
was observed in 90% of the CA1 pyramidal neurons and in
Table 1. Neurological characterization of CKIIcre/CBPf/f and control littermates
CBPf/f (n 9) CKIIcre/CBPf/f (n 10) p
Weight (g) 28.6 0.94 30.2 0.53 0.16
Body length (mm) 90 (90–96.5) 97.5 (93.75–100) 0.02
Body position 3 (2–3.25) 3 (2–3) 0.54
Spontaneous activity 2 (1–2) 2 (1–2) 0.65
Respiration rate 2 (2–2) 2 (2–2) 1.00
Tremor 0 (0–0) 0 (0–0) 1.00
Barbering 0 (0–0) 0 (0–1) 0.36
Urination 0 (0–0) 0 (0–0) 1.00
Defecation 0.5 (0–1.25) 0 (0–0) 0.08
Transfer arousal 4 (2–4.25) 4 (1–4) 0.39
Fear 1 (0.75–1) 1 (1–1) 0.15
Palpebral closure 0 (0–0) 0 (0–0) 1.00
Piloerection 0 (0–0) 0 (0–0) 1.00
Gait 0 (0–0) 0 (0–1) 0.13
Pelvic elevation 3 (2.75–3) 3 (2–3) 0.65
Tail elevation 1 (1–1) 1 (1–1) 0.32
Touch scape 2 (2–2) 2 (1–2) 0.16
Positional passivity 0 (0–0) 0 (0–0.25) 0.54
Trunk curl 0 (0–0) 0 (0–0) 1.00
Feet clasping 1 (1–1) 1 (1–1) 1.00
Limb grasping 1 (1–1) 1 (1–1) 1.00
Visual placing 2 (2–2) 2 (2–2) 1.00
Negative geotaxis 0 (0–0) 0 (0–0) 0.32
Grip strength 3 (3–3) 3 (3–3) 0.32
Pinna reflex 1 (0.75–2) 1.5 (0.75–2) 0.52
Corneal reflex 2 (2–2) 2 (2–2) 0.32
Toe pinch 0.5 (0–3) 1.5 (0–2.25) 0.78
Pole latency (up) 2 (0–6.25) 2 (0–6.75) 1.00
Pole latency (down) 1 (0–4.75) 2 (0–3) 0.90
Wire maneuver 2 (1–3) 1.5 (0.75–2) 0.16
Righting reflex 0 (0–0) 0 (0–0) 1.00
Contact righting reflex 1 (1–1) 1 (1–1) 1.00
Irritability 0 (0–0) 0 (0–0) 0.32
Vibrissae 1 (0–1) 1 (1–1) 0.28
Skin color 1 (1–1) 1 (1–1.25) 0.54
Limb tone 1 (1–1) 1 (1–1) 1.00
Abdominal tone 1 (1–2) 1 (1–1.25) 0.24
Lacrimation 1 (1–1) 1 (1–1) 1.00
Provoked biting 1 (0–1) 0.5 (0–1) 0.37
Aggression 0 (0–0) 0 (0–0) 1.00
Vocalization 0 (0–1) 0 (0–0.25) 0.34
Seizures 0 (0–0) 0 (0–0) 1.0
Hotplate 12.7 0.66 11.9 0.53 0.39
Data are expressed as either mean SEM or median, followed by the interquartile range in parentheses. p values
are calculated using t test for data expressed asmean SEM orMann–Whitney test for data expressed asmedian,
followed by the interquartile range.
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40% of the granular cells of the dentate gyrus (DG); no loss of
CBP was observed in the CA3 subfield (Fig. 1G). The pattern of
CBP elimination in the cortex also showed interesting asymme-
tries. We observed a general reduction of CBP throughout the
cortex (Fig. 1E), but layers 2 and 3 seemedmore severely affected
(70% of the cells; data not shown) than the other layers. The
loss of CBP also affected most principal neurons in the amygdala
formation, whereas immunostaining in the cerebellum was sim-
Figure1. Forebrain-specific recombination of the crebbp locus.A, Schemeof the crebbp locus showing the loxP sites (thick arrows) surrounding exon 7. Primers for checking recombination at the
genomic DNA [named Z38 and Z40 (Zhang et al., 2004)] and transcript levels (named 5CBD and E8rev) are also depicted. B, The recombination of genomic DNA (band marked as “recomb”) was
detected only in genomic DNA from cre-expressing tissues (Ctx, cortex; Hpc, hippocampus; Str, striatum) but not in the cerebellum (Cb) or the tail. MW, Molecular weight markers. C, Exon-specific
RT-PCR using 5CBD and E8rev primers identifies two different transcript specieswith the expected sizes of 370 and 267 bp, confirming the deletion of exon 7 in the cortex but not in the cerebellum.
D, QuantitativeRT-PCRofRNA fromCKIIcre/CBPf/fand control littermates (n4pergenotype)usingaprimerpair specific for full-lengthCBP transcripts (E7fwdandE8rev) or apair of primers located
3 in the KAT domain (3). E, Immunohistochemistry analysis of CBP demonstrates that the expression of cre recombinase driven by the CaMKII--cre transgene is scattered over the cortex and
hippocampus. CBP loss is also appreciable at the amygdala but not in the cerebellum in which cre recombinase is not expressed. The different cortical layers (I–VI) and other anatomical landmarks
are indicated. CA1, CA1 subregion; CA3, CA3 subregion; DG, dentate gyrus; LA, lateral amygdala; BA, basal amygdala; Str, striatum; ML, molecular layer; GL, granular layer. Scale bar, 100m. F,
Higher-magnification image of the CA1 subregion demonstrating the existence of two distinct populations of CA1 pyramidal neurons: CBP positive and CBP negative. Scale bar, 50m. G, Left,
Quantificationof theCBP-positive cells in different brain regions. Right, DAPI staining showed that a similar number of cellswere analyzed inbothgroups of animals. CBPf/f,n2; CKIIcre/CBPf/f,n
3. Data are expressed as mean SEM. *p 0.01; **p 0.001.
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ilar in CKIIcre/CBPf/f and control mice.
Because of the prominent reduction of
CBP in the CA1 subfield of the hippocam-
pus, we focused our analyses primarily in
this area.
CBP loss causes a strong reduction of
neuronal histone acetylation
The reduction of CBP levels (and conse-
quently of its KAT activity) has been asso-
ciated with histone hypoacetylation. In
previous analyses of cbp/ mice, we de-
tected a significant reduction of neuronal
histone H2B acetylation (Alarco´n et al.,
2004), but the neurons of these animals
still maintained a functional crebbp al-
lele. Neurons with disruption in both
alleles represent a better approach to
clarify the contribution of the activity of
CBP to the acetylation of each one of the
four nucleosome histones and to deter-
mine the substrate preference of this en-
zyme in neurons.
Western blot analyses in the CA1 sub-
region revealed a significant (50%) re-
duction in the acetylation of bulk histones
H2B and H2A and a trend indicating also
reduced acetylation of histones H3 and
H4 (Fig. 2A). To gain additional detail, we
used immunohistochemistry staining and
confocal microscopy and took advantage
of the scattered pattern of CBP loss. This
circumstance allowed the direct compari-
son of neighboring CBP-expressing and
CBP-lacking neurons in the same field of
view.We found that the same cells lacking
CBP also showed a dramatic reduction in
the acetylation of the four nucleosome hi-
stones. This reduction was especially se-
vere in the case of histones H2B and H2A,
although the acetylation of histones H3
and H4 was also significantly reduced
(Fig. 2B,C). The same pattern, pronounced
decrease of H2A/H2B acetylation andmore
modest reduction of H3/H4, was also ob-
served in cortical and dentate gyrus neu-
rons (supplemental Fig. S1, available at
www.jneurosci.org as supplemental ma-
terial). The analysis of the correlation
betweenCBP expression andhistone acet-
ylation levels in individual cells indicates
that the KAT activity of CBP contributes
to the acetylation state of the four nucleo-
some histones but is especially important
in determining the acetylation level of his-
tones H2A and H2B (Pearson’s correla-
tion coefficient of 0.78 for AcH2A, 0.79
Figure 2. Strong reduction of histone acetylation in CKIIcre/CBPf/fmice. A, Quantification of the results of Western blots of CA1
subregion protein extracts from CKIIcre/CBPf/fmice and control littermates using--actin,-H2B and-H3 (non-acetylated),
-AcH2B, -AcH2A, -AcH3, and -AcH4 antibodies (n 6 for CBPf/f and n 5 for CKIIcre/CBPf/f). Data are expressed as
mean SEM. See representative blot results in Figure 3.We included samples frommice injected with NaBu or vehicle (PBS) as a
control (results not shown). B, Representative images of the cellular layer in the CA1 subfield of CKIIcre/CBPf/f mice and control
littermates. Sagittal brain sections were immunostained with antibodies against the acetylated forms of histones H2A, H2B, H3,
and H4 (green fluorescence) and against CBP (red fluorescence). Mutant mice showed important reduction in AcH2A and AcH2B
followed by AcH3 and AcH4. Note the single-cell correlation between levels of CBP and acetylation. Scale bar, 50 m. C, The
quantification of immunohistochemistry signal in individual neurons revealed that in the CA1 subfield of CKIIcre/CBPf/f mice the
4
CBP cells maintain higher levels of histone acetylation than
CBP cells. The difference is especially dramatic in the case of
AcH2B and AcH2A. *p 0.01; **p 0.001.
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for AcH2B, 0.62 for AcH3, and 0.69 for AcH4). Interestingly,
intraperitoneal injection of the HDACi sodium butyrate was able
to restore and even to increase the histone acetylation levels in the
brain of CKIIcre/CBPf/f mice, indicating that other cellular KAT
activities also have these histones as substrates (Fig. 3 and results
not shown).
To confirm the apparent preference of KAT activity by CBP
for histones H2A and H2B versus H3 and H4, we overexpressed
CBP inHEK293 cells and performedWestern blots for each of the
four acetylated histones. In agreement with our observations in
knock-out mice, the overexpression of CBP affected more the
acetylation state of histonesH2B andH2A than that ofH3 andH4
(Fig. 4A,B). In the case of H2B acetylation, we also explored the
specificity for the different lysine (K) residues in the N-terminus
tail. CBP did not show a clear specificity and caused the hyper-
acetylation of K5, K12, K15, and K20 (Fig. 4C,D). Interestingly,
although the paralogous KAT p300 exhibited the same specificity
in these in vitro assays, it cannot compensate the loss of CBP in
neurons in vivo.
Overall, these experiments identify CBP as the main KAT ac-
tivity responsible for the steady-state level of acetylation of the
H2A/H2B dimers but also suggest that there are other KAT ac-
tivities present in the cell that have these histones as substrate
when HDACis disrupt the acetylation/deacetylation balance.
The elimination of CBP and ensuing histone hypoacetylation
is not critical for neuronal viability
The reduction of CBP activity and histone acetylation has been
proposed to have a causal role in neurodegenerative diseases;
therefore, we explored in CKIIcre/CBPf/f mice whether the neu-
ronal elimination of CBP was associated with neuronal death in
the adult brain.
We did not observe any reduction in brain weight (values in
8-month-old mice: CBPf/f, 0.37 0.01 g; CKIIcre/CBPf/f, 0.39
0.01 g; n 4 for both genotypes) nor apparent loss of neurons in
the brain areas showing extensive ablation of CBP neither at the
time of the analyses presented above (2- to 3-month-old mice,
4,6-diamidino-2-phenylindole (DAPI) panels in Fig. 2 and data
not shown) nor 5 months later (8-month-old mice in Fig. 5A).
Thus, the thickness of the cell layers in the CA1 and DG subfields
were similar in mutant and control mice (Fig. 5B), and both the
relative thickness of the cortical layers and the number of cortical
neurons were maintained in CKIIcre/CBPf/f mice despite the
strong differences in histone acetylation and CBP expression
(Fig. 5C and results not shown). Moreover, Neurosilver staining
did not reveal cell death or tissue damage (Fig. 5D). The immu-
nostaining with anti-GFAP and anti-NeuN antibodies to detect
astrogliosis and the loss of neurons, respectively, did not reveal
any difference between the two genotypes (Fig. 5E) [NeuN-
positive (NeuN) cells/mm2: CBPf/f, 1130.14 50.11; CKIIcre/
CBPf/f, 1148.97  48.06; GFAP cells/mm2: CBPf/f, 452.05 
21.41;CKIIcre/CBPf/f, 466.61 37.63; n 4 for both genotypes].
Immunostaining for the dendritic marker MAP2 and the synap-
tic marker synaptophysin (supplemental Fig. S2, available at
www.jneurosci.org as supplemental material) also supported the
anatomical integrity of the hippocampus in CKIIcre/CBPf/fmice.
As mentioned previously, neurons contain a second KAT en-
zyme highly homologous to CBP, p300, which has been also as-
sociated with RSTS and has similar substrate preferences (Fig. 4).
We testedwhether CBP loss caused a compensatory upregulation
of p300, whichmight prevent neuronal death. qRT-PCR assay for
p300 transcripts did not reveal significant differences between
CKIIcre/CBPf/f and control littermates, indicating that the over-
expression of p300 does not compensate for the reduction of CBP
(Fig. 5F).
Expression and novelty induction of IEGs in CBP-lacking
hippocampal neurons
Both functions ofCBP, asKATand as transcriptional coactivator,
have been linked to activity-driven gene expression.We therefore
investigated whether CBP loss blocked the hippocampal induc-
tion of IEGs in response to novelty, a process likely required for
the consolidation of hippocampal-dependent memory (Lisman
and Grace, 2005; Moncada and Viola, 2007). To address this
question, we analyzed the induction of seven representative IEGs
[fos, npas4, arc, dusp1, egr1 (also known as zif268), nr4a1 (also
known as nur77), and fosB] in response to 1 h of novelty exposure
(NE) (Sheng et al., 1990; Patterson et al., 1992). qRT-PCR anal-
Figure 3. CBP-dependent histone acetylation deficits can be reversedwith sodiumbutyrate.A, Representative result ofWestern blot analyses of CA1 subfield protein extracts from CKIIcre/CBPf/f
mice and control littermates injected with sodium butyrate (NB) or PBS using--actin,-H2B and-H3 (non-acetylated),-AcH2B,-AcH2A,-AcH3, and-AcH4 antibodies. B, Quantifi-
cation of theWestern blots against AcH2B and AcH3 in hippocampal extracts from CBPf/f and CKIIcre/CBPf/fmice treated with vehicle (V, solid bars) or sodium butyrate (NB, hatched bars). Data are
expressed as mean SEM. n 4 for both genotypes. *p 0.05; **p 0.01; #p 0.01 in the comparison between genotypes. C, Representative images of the cellular layer in the CA1 subfield
of CKIIcre/CBPf/fmice and control littermates treated with NaBu or PBS and stained with-AcH2B. Scale bar, 50m.
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yses of hippocampal samples showed a
clear induction for all these genes in re-
sponse to NE but did not reveal any
change depending on genotype (Fig. 6A).
Because this result was unexpected and
there was a trend indicating a possible re-
duction in transcript level for some of
these genes, we repeated the experiment
with an independent group of mice in
which we microdissected the CA1 sub-
field, a region in which CBP depletion was
particularly extensive. qRT-PCR analyses
of CA1 samples revealed a more clear
trend toward a reduction of the induction
of some of these IEGs in CKIIcre/CBPf/f
mice (Fig. 6B). However, the two-way
ANOVA of CA1 qRT-PCR data did not
reveal significant interaction between ge-
notype and condition (home cage vs nov-
elty) for the expression of any of these
IEGs, although the expression of egr1,
dusp1, and nr4a1 showed a significant ge-
notype effect (Table 2). The multivariate
ANOVA (MANOVA) of transcript levels
for this group of genes did not show sig-
nificant genotype effect or interaction
with condition (Table 2). Overall, these
analyses demonstrate that the expression
of some of IEGs is slightly reduced in the
hippocampus of CKIIcre/CBPf/f mice, but
the ability for induction in response to
novelty is still essentially preserved in the
absence of CBP.
To explore further this lack of effect, we
examined in greater detail the expression of
c-fos, an IEG previously shown to depend
on CBP function (Korzus et al., 2004) but
whose inductionwas unaffected inCKIIcre/
CBPf/f mice, using immunohistological
techniques.As reportedpreviously, c-fos in-
duction on novelty was detected in a large
number ofCA1pyramidal neurons and in a
few scattered granule cells of the dentate gy-
rus (Hess et al., 1995;Wallace et al., 1995; Chawla et al., 2005) (sup-
plemental Fig. S3, available at www.jneurosci.org as supplemental
material). Again, we took advantage of the scattered pattern of
CBP loss and concurrent reduction of histone acetylation to com-
pare the induction of IEG in CBP-positive and CBP-negative
CA1 pyramidal neurons of a given animal. The double immuno-
staining of brain sections with antibodies against c-fos and CBP
revealed that a similar number of cells responded to the novelty
paradigm in CKIIcre/CBPf/fmice and control littermates (percent-
age c-fos cells:CBPf/f, 33.54 4.15;CKIIcre/CBPf/f, 30.54 3.47).
Moreover, c-fos induction was observed in both CBP-positive and
CBP-negative cells in the CA1 subfield of CKIIcre/CBPf/fmice [per-
centage c-fos cells: among CBP cells, 19.35 7.60; among CBP-
negative (CBP) cells, 32.41  5.32]. No correlation, either
positive or negative, was found between the novelty-triggered
induction of c-fos expression and CBP-dependent histone
acetylation in individual pyramidal cells at the CA1 subregion
(Pearson’s correlation coefficient in CKIIcre/CBPf/f mice 
0.02).
Behavioral deficits in CKIIcre/CBPf/f mice
Previous behavioral studies in several CBP-deficient strains
(heterozygous or transgenic) have demonstrated that the re-
duction of CBP function causes long-term memory deficits
and other behavioral impairments (Barco, 2007). However,
these studies have left some important open questions such as
the identification of the anatomical substrate for these deficits
and the distinction between developmental and adult func-
tions of CBP. We therefore investigated the behavioral pheno-
type of CKIIcre/CBPf/f mice to gain insight into these issues.
We first subjected CKIIcre/CBPf/f mice to a comprehensive
battery of basal neurological tests, the SHIRPA modified screen
(Viosca et al., 2009, 2010). No differences were observed in basic
reflexes, strength,muscle tone, and other parameters evaluated in
this primary screen except for the slight increase in body length
commented above (Table 1). Next, we examined the behavior of
CKIIcre/CBPf/f mice in an open field, a test for anxiety and basic
locomotor and exploratory behavior. Ambulatory distance in a 30
min test (CBPf/f, 59.63  3.49 m; CKIIcre/CBPf/f, 64.72  4.00 m;
t(17)  0.95; p  0.36), percentage of distance in the center of the
Figure 4. Substrate specificity of CBP. A, Western blot analysis of acetylation for the four nucleosome histones in extracts of
HEK293 cells transfected eitherwith a plasmid encoding CBP (C) or p300 (P) orwith an empty vector (E). Hyperacetylationwas only
observed in AcH2A and AcH2B when cotransfected with the plasmid pTet–Off but not with an unrelated vector (pGFP) that not
expressed the required tTA to achieve maximum levels of KAT protein expression. CBP and p300 showed similar substrate speci-
ficity. B, Quantification of Western blot results in A. C, Substrate specificity of CBP in H2B acetylation. Western blot analysis of
acetylation for the four lysine residues at the N-terminal tail of histone H2B in extract of HEK293 cells transfected either with a
plasmidencodingCBPorp300orwithanemptyvector.D, Quantificationof thedata inC. DataareexpressedasmeanSEM.*p
0.05; **p 0.01; ***p 0.001.
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arena (CBPf/f, 6.05 0.75;CKIIcre/CBPf/f, 5.92 0.88; t(17) 0.10;
p0.92),which is a commonmeasure of anxiety, andother param-
eters such as stereotypic time, resting time, and vertical activity were
similar for both genotypes. We exposed the animal to the same box
in three additional sessions. This caused habituation in wild types,
and the total traveled distance decreased between sessions (Fig. 7A)
(CBPf/f, F(2,16)Day 6.61; p 0.01) but not in CKIIcre/CBP
f/f mice
(Fig. 7A) (CKIIcre/CBPf/f,F(1.1,10.5)Day 3.62; p 0.08). Locomotor
activity was also assessed using the automatic system Phenotyper for
aperiodof 72h (Fig. 7B).BothCKIIcre/CBPf/fmice and their control
littermates exhibitedmore activity during the dark phase of the light
cycle (t test dependent samples, t(9)7.94,p0.00and t(8)10.97,
p  0.00, respectively). CKIIcre/CBPf/f mice showed more diurnal
activity than their control siblings (F(1,17)genotype31.01;p0.001).
We also studied thesemice in the elevated plusmaze, a task inwhich
mice face a conflict between their tendency to explore new environ-
ments and their innate aversion to open spaces. BothCKIIcre/CBPf/f
and control mice showed a similar number of entries and spent the
same amount of time in the open arms (Fig. 7C) (t(17) 0.28; p
0.78; results not shown). Togetherwith the observations in the open
field, these parameters indicate normal levels of anxiety.
We examined next the animals’ performance in an acceler-
ated paradigm for the rotarod task, a motor coordination and
learning task in which cbp/mice were impaired (Alarco´n et
Figure 5. Loss of CBP does not cause neuronal death. A, Nissl staining of brain sagittal sections of an 8-month-old CKIIcre/CBPf/f mouse and a control (CBPf/f) littermate did not show gross
abnormalities. Scale bar, 150m.B, The thickness of the CA1 andDG (upper and lower blades)were not significantly reduced in CKIIcre/CBPf/fmice (n 4 per genotype). C, The thickness of cortical
layers and the number of cortical neurons (data not shown) were also not affected (n 4 per genotype). Up, Cortical upper layers (II–III); Low, cortical lower layers (IV–VI). PtA cortex, Parietal
associative cortex.D, Neurosilver staining in brain slices from CKIIcre/CBPf/f and controlmice did not reveal any overt difference and dark cells (i.e., degenerating neuron)were not detected in either
genotype. Scale bar, 50m. E, Representative images of the cellular layer in the CA1 subfield of CKIIcre/CBPf/f and control mice in slices immunostainedwithmarkers for mature neurons (NeuN) or
glial cells (GFAP) and counterstained with DAPI (not shown). Scale bar, 50m. F, qRT-PCR quantification of p300 mRNA in the hippocampus (Hpc) and cortex of CKIIcre/CBPf/f mice and control
littermates (n 4 per genotype). Similar results were obtained with microdissected CA1 subfield samples (data not shown).
Figure6. Induction of IEGs by novelty in CKIIcre/CBPf/fmice.A, qRT-PCR of indicated IEGs in hippocampal samples from CKIIcre/CBPf/f and control siblings after exploration of a novel environment
for 1 h (NE) or kept in their home cages (HC) (n 4, for all conditions). B, Quantitative RT-PCR of the same IEGs in microdissected CA1 subregions of CKIIcre/CBPf/f mice and control siblings after
exploration of a novel environment for 1 h (n values: CBPf/f HC, 6; CBPf/f NE, 7; CKIIcre/CBPf/f HC, 5; and CKIIcre/CBPf/f NE, 7). *p 0.05 (two-way ANOVA genotype effect; for additional details, see
Table 2). C, c-fos immunostaining of the CA1 subfield did not reveal changes in c-fos induction between CKIIcre/CBPf/fmice and control siblings (2–3 mice per group). Scale bar, 25m.
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al., 2004). Interestingly, we did not observe any impairment in
CKIIcre/CBPf/f mice (latency to fall: CBPf/f, 275.5  11.1 s;
CKIIcre/CBPf/f, 275.3 17.4 s; t test, t(17)0.57; p 0.99).
Also, we found no difference between the two genotypes in the
hotplate test, a test to measure nociception and sensitivity to
thermal stimulus (Table 1).
Next, we examined the performance ofCKIIcre/CBPf/fmice in
a novel object recognition memory task, a non-aversive memory
task that relies on the natural exploratory behavior of mice and
that has consistently revealed memory deficits in all the CBP-
deficient strains analyzed so far (Barco, 2007). As expected, con-
trol mice spent more time exploring the novel object during
testing (Fig. 7D) (CBPf/f vs 0, t(8) 5.05; p 0.001). In contrast,
CKIIcre/CBPf/f mutants spent similar time exploring the novel
and the old object (Fig. 7G) (CKIIcre/CBPf/f vs 0, t(9) 1.25; p
0.24), indicating that, like other CBP-deficient strains previously
analyzed, CKIIcre/CBPf/f mutants have impaired long-term rec-
ognition memory.
To continue with the analysis of cognitive abilities, we exam-
ined the performance ofCKIIcre/CBPf/fmice in spatial navigation
using theMWM. In agreement with preceding studies on cbp/
mice, we did not detect significant differences between groups in
neither the visible nor the hidden platform tasks. The path
lengths and the latencies to find the platform declined with sim-
ilar slope over training inmutant and control littermates (Fig. 7E
and results not shown). The probe trials performed on days 5 and
8 did not reveal any statistical difference in the performance as-
sociated with the genotype (Fig. 7F). In agreement with our ob-
servations in the rotarod supporting normalmotor performance,
we found that, conversely to heterozygous mice (Alarco´n et al.,
2004), these mutants did not swim slower than their control lit-
termates (F(1,17)genotype 0.73, p 0.40; F(7,119)genotype  session
0.30, p 0.95).
Finally, we assessedCKIIcre/CBPf/fmice in two fear condition-
ing tasks that measure the capability of the mouse to form asso-
ciations between an aversive stimulus (mild footshock) and
neutral environmental cues, such as the spatial context in the case
of contextual fear conditioning, and a tone delivered simulta-
neously to the shock in the case of the cued fear conditioning.
Conversely to our previous observations in cbp/ mice, but in
agreement with previous findings in transgenicmice expressing a
truncatedCBP variant driven by theCaMKII promoter (Korzus
et al., 2004), CKIIcre/CBPf/f mutants showed the same level of
freezing as control mice in both tasks (Fig. 7G).
Discussion
The role of epigenetic mechanisms of regulation of gene expres-
sion in cognition has attracted great interest in recent years
(Hsieh and Gage, 2005; Levenson and Sweatt, 2005; Tsankova et
al., 2007; Borrelli et al., 2008; Zocchi and Sassone-Corsi, 2010).
Our study represents an important contribution to this rapidly
progressing field because the analysis of brain-specific crebbp
knock-outs did not only provide novel insight into RSTS etiol-
ogy, it also clarified important open questions concerning the
substrate preferences of CBP and the role of CBP and histone
acetylation in neurodegeneration, activity-driven gene expres-
sion, and memory formation.
CBP loss and reduced histone acetylation do not interfere
with neuronal viability: implications for neurodegenerative
diseases
A number of studies have shown that the pathogenesis of Alzhei-
mer’s disease (AD) and Huntington disease (HD) is accompa-
nied by the selective downregulation of genes involved in
neuroplasticity and suggested that transcriptional deregulation
may represent an early mechanism of pathology in both diseases
(T. Shimohata et al., 2000a,b;M. Shimohata et al., 2005; Obrietan
andHoyt, 2004; Fischer et al., 2007; Palop et al., 2007).Moreover,
in the case of HD, the deregulation of gene transcription has been
specifically linked to the sequestration of CBP in huntingtin ag-
gregates (McCampbell et al., 2000;Nucifora et al., 2001; Steffan et
al., 2001). Independent studies have shown that the administra-
tion of HDACis attenuates neuronal loss in animal models for
HD (Steffan et al., 2001; Ferrante et al., 2003; Hockly et al., 2003),
AD (Fischer et al., 2007), and other neurodegenerative diseases
(Minamiyama et al., 2004;Mai et al., 2009). Based onboth lines of
evidence, it has been proposed that epigenetic changes in the
chromatin play a role in neurodegeneration and that targeting
the balance between histone acetylation and deacetylation may
hold great potential for neuroprotection and neurorestoration
(Fischer et al., 2007; Chuang et al., 2009; Mai et al., 2009). The
evidence presented here indicates that the relationship between
histone acetylation and neurodegeneration ismore complex than
expected. CKIIcre/CBPf/f mice exhibit a dramatic reduction of
histone acetylation, particularly of histones H2A and H2B, and
this does not seem to affect neuronal viability, indicating that
sustained low levels of histone acetylation do not necessarily
cause neuronal death. In agreement with this view, no neurode-
generative process has been ever reported in RSTS patients or in
animalmodels for this condition (Wiley et al., 2003; Barco, 2007).
How to explain the apparent discrepancy between the absence
of neurodegeneration in mice lacking CBP and the beneficial
effects of HDACi? Maybe promoting histone acetylation is ben-
eficial under cellular stress conditions but does not affect neuro-
nal viability in normal situations. Alternatively, the biologically
relevant targets of these pathological conditions may be H3/H4
and cellular KAT activities other than CBP, whereas the reduc-
tion of the acetylation of H2A and H2B are mere side effects.
However, the fact that H3 and H4 acetylation is also reduced in
CKIIcre/CBPf/f mice argues against this possibility. One might
also consider that the requirement for CBP is not cell autono-
mous, and CBP-positive neurons adjacent to CBP-negative neu-
rons might prevent their death through, for example, the release
of neurotrophic factors. It is also possible that 	8 months are
needed to see the deleterious consequences of CBP elimination
because AD and HD are two slowly progressing diseases. Finally,
our results also open the possibility that the beneficial effects of
HDACi are not related to histone acetylation but to other non-
histone substrates of HDAC enzymes, such as transcription fac-
tors or cytoskeleton proteins. Nevertheless, the lysine acetylome
consists on hundreds of substrates involved in numerous func-
tions (Choudhary et al., 2009).
Table 2. Summary of two-way ANOVA andMANOVA of qRT-PCR data for IEG
expression inmicrodissected CA1 subregions
Two-way ANOVA
p value
Condition Genotype Condition genotype
arc <0.001 0.21 0.26
fos <0.001 0.19 0.23
npas4 <0.001 0.15 0.53
egr1 <0.001 0.003 0.21
nr4a1 <0.001 0.007 0.25
fosB <0.001 0.19 0.29
dusp1 <0.001 0.027 0.45
MANOVA <0.001 0.25 0.97
Significant ( p 0.05) effects are indicated in bold.
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CBP-dependent histone acetylation and activity-driven
gene expression
Studies in cbp/ mice have demonstrated that CBP deficiency
causes the reduction of histone H2B acetylation (Alarco´n et al.,
2004). This seminal finding was rather surprising, because bio-
chemical assays and studies in cultured cells had identified his-
tone H2B as a substrate for the KAT activity of CBP but did not
reveal this level of specificity (McManus and Hendzel, 2003;
Kouzarides, 2007). The experiments presented here extend the
analysis of the substrate specificity of CBP in vivo in the CNS.Our
results suggest that the balance of KAT and HDAC activities in
hippocampal neurons makes the acetylation of the N-terminal
tail of histones H2A and H2B, especially the second one, more
sensitive to changes in CBP activity than those of histone H3 and
H4. Our experiments with NaBu also indicate that, although the
KAT activity of CBP seems to be primarily responsible for the
basal acetylation state of H2A andH2B, other KAT activities with
this specificity, such as p300, become active when the steady-state
acetylation/deacetylation balance is disrupted by HDACis.
The pair H2A/H2B forms dimers, whereas H3/H4 forms tet-
ramers. Both structures have different affinities for the DNA and
play different roles on chromatin structure and transcription
(Kouzarides, 2007). Although the role of H2A and H2B acetyla-
tion in transcription has been, in general, less studied than forH3
and H4, the acetylation of H2A/H2B dimers is thought to facili-
tate their release from the chromatin (Ito et al., 2000). The pres-
ence of acetylated H2B seems to be a feature of only the most
active genes and has been associated with the maintenance of the
overall transcriptional competence of specific loci (Myers et al.,
2003). In fact, a recent study identified AcH2B(K5) as one of the
posttranslational histone posttranslational modification more
strongly associated with gene expression levels (Karlic´ et al.,
2010). Our results seem to indicate that this may be a conse-
quence rather than a cause of the high transcriptional activity and
suggest that, although the acetylation of H2A/H2B may enhance
transcription, it is not strictly necessary for activity-driven gene
induction. Our results also indicate that CBP is not an essential
coactivator for the induction of the IEGs analyzed in this work,
despite the fact that the promoters of these genes contain the
DNA binding motifs for the binding of activity-regulated tran-
scription factors known to interact with CBP. This conclusion
challenges the proposed, but still unconfirmed, critical role of
CBP and activity-driven histone acetylation in memory-related
transcription, but it is in good agreement with previous studies in
cbp/mice after kainate-induced seizures (Alarco´n et al., 2004)
andwith recent observations in primarymouse embryonic fibro-
blasts, demonstrating that the elimination of both CBP and p300
does not prevent the induction of IEGs by forskolin (Kasper et al.,
2010).
Novel insights into RSTSmental impairment: anatomical
substrates and dissociation of developmental and postnatal
deficits
The behavioral analysis ofCKIIcre/CBPf/fmice has revealed inter-
esting deficits, such as slightly decreased locomotor habituation
andobject recognitionmemory impairment.However, these def-
icits were more modest than expected considering the early le-
thality of the conventional knock-outmice and the importance of
the functions allocated to this protein. A factor to consider in the
interpretation of cognitive deficits in CKIIcre/CBPf/fmice (or the
lack of them) is themosaic pattern ofCBP ablation. Although this
feature has been very useful in our correlative studies on individ-
ual cells, it represents a caveat for behavioral experiments because
we cannot discard that the remaining CBP cells in hippocam-
pus, amygdala, or other structures are sufficient to support the
assessed forms of memory.
Important information can be extracted nevertheless from the
comparison between CBP-deficient strains (see comparison of
Figure 7. Locomotor activity, anxiety, learning, andmemory in CKIIcre/CBPf/fmice. A, CKIIcre/CBPf/fmice initially behave as control mice in an open field (see Results), but amodest difference in
locomotor habituationwas observedwhen themicewere exposed to the samearena during 3 consecutive days (CBPf/f,n 9 and CKIIcre/CBPf/f,n 10).B, CKIIcre/CBPf/fmice showedmore activity
in the Phenotyper boxes during the light phase of the day. C, CKIIcre/CBPf/fmice showed normal anxiety asmeasured in the elevated plusmaze. OA, Open arm; CA, closed arm.D, CKIIcre/CBPf/fmice
showed impairedmemory for object recognitionwhen tested 24h after training.E, No significant differences betweengenotypeswere observedduring training in both the visible platform (V1–V3)
and the hidden platform tasks (H1–H8). F, Spatial memory was assessed in two probe trials (P1 and P2), and no significant difference was observed in the percentage of time spent in the target
quadrant (TQ) or in the number of annulus crossings.G, Normal freezing in contextual and cued conditioning 24 h and 1week after training (CBPf/f, n 9 and CKIIcre/CBPf/f, n 10). PS, Preshock;
Cx, context test; PT, pretone; Tn, tone test.
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previous RSTSmodels by Josselyn, 2005; Barco, 2007). For exam-
ple, some noncognitive impairments, such as the reduced swim-
ming speed or the poor rotarod performance observed in
heterozygous mice but absent in CKIIcre/CBPf/f mice, are likely
developmental or caused by CBP deficiency in cell types not tar-
geted in the forebrain-specific knock-outs, such as the Purkinje of
granular cells in the cerebellum. Also, we confirmed the particu-
lar sensitivity of object recognition memory to the reduction of
CBP function and identified the hippocampus and cortical areas
as the most likely anatomical substrate for this cognitive impair-
ment. The impaired expression of the activity-regulated genes
egr1, nr4a1, and dusp1 in the hippocampus of CKIIcre/CBPf/f
micemight contribute to thismemory impairment because slight
changes of nr4a1 induction have been associated to the memory-
enhancing effects of the HDACi trichostatin A (Vecsey et al.,
2007). Spatial navigation and fear conditioning tasks have pro-
duced less consistent results in RSTS mouse models. Both tasks
did not show any impairment in forebrain-restricted knock-outs,
indicating either that the small remaining population of CBP-
positive neurons is sufficient to sustain these memories or that
CBP function in the postnatal brain is not critical for these forms
of learning, which is in agreement with previous observations in
other forebrain-specific CBP-deficient strains (Korzus et al.,
2004). Interestingly, it has been shown recently that acetylation of
K12 in histone H4maymediate gene induction in the contextual
fear conditioning paradigm (Peleg et al., 2010). Although the
mainKAT activity underlying this posttranslationalmodification
has not been yet identified, it is plausible that specific KAT activ-
ities are required for different learning tasks and memory pro-
cesses in different brain areas. Additional studies are necessary to
determine the still obscure function of histone acetylation in cog-
nition and mental retardation.
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